Adverse events with sodium-glucose co-transporter-2 inhibitors: AÂ global analysis of international spontaneous reporting systems
Keywords: Gliflozins; Sodium-glucose co-transporter-2 inhibitors; Spontaneous reporting system; Pharmacovigilance; Disproportionality; Skin toxicity;